SCHEMBL17755510

SCHEMBL17755510

Clc1cc2c(cc1Cl)NC1(CCCCC1)C(NCc1cccnc1)=N2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ HK1 P19367 1/20 0.38
▸ HKDC1 Q2TB90 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ BCL6 P41182 1/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ PDE1A P54750 1/20 0.37
▸ PDE1B Q01064 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ PDE7A Q13946 1/20 0.37
▸ PDE1C Q14123 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ PDE7B Q9NP56 1/20 0.37
▸ LTA4H P09960 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757139 0.88 CDK2 (0.41) KMT2AMEN1ALDH1A1BCL6PGK1
SCHEMBL17757643 0.88 KMT2A (0.40) KMT2AALDH1A1PDE5APDE1APDE1B
SCHEMBL17757638 0.88 KMT2A (0.40) KMT2AALDH1A1PDE5APDE1APDE1B
SCHEMBL17757626 0.88 KMT2A (0.40) KMT2AALDH1A1PDE5APDE1APDE1B
SCHEMBL17757436 0.85 MAOB (0.36) KMT2ACYP3A4
SCHEMBL17757642 0.85 MAOB (0.36) KMT2ACYP3A4
SCHEMBL17755503 0.85 LTA4H (0.43) HSD17B10KMT2AMEN1TDP1ALDH1A1
SCHEMBL17758109 0.83 CYP1A2 (0.39) HSD17B10KMT2AMEN1TDP1ALDH1A1
SCHEMBL17758102 0.83 CYP1A2 (0.39) HSD17B10KMT2AMEN1TDP1ALDH1A1
SCHEMBL17757639 0.81 GAA (0.37) HSD17B10RAB9AALDH1A1PDE7ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 HSD17B10 1082/4885RAB9A 4069/4885KMT2A 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback